September 2026

First new CANTAB® product features developed & launched from the landmark INTUITION project

/ Events, Insights, Webinars

First new CANTAB® product features developed & launched from the landmark INTUITION project Cambridge Cognition (AIM: COG), the neuroscience technology company, announces two new product features for its CANTAB digital cognitive assessments derived from analysis of data from the INTUITION project. ​​​Application of Expanded Normative Dataset – Increased Sensitivity and Accuracy of CANTAB® ​The first […]

First new CANTAB® product features developed & launched from the landmark INTUITION project Read More »

C2N Diagnostics Expands Global Partnerships in United Kingdom on World Alzheimer’s Day, Joins Cambridge Cognition and The Alzheimer’s Trust to Improve Alzheimer’s Disease Diagnosis

/ News

Collaboration integrates cognitive assessment, proprietary blood test, national phlebotomy and MRI infrastructure to accelerate patient diagnosis and care pathways throughout the UK.

C2N Diagnostics Expands Global Partnerships in United Kingdom on World Alzheimer’s Day, Joins Cambridge Cognition and The Alzheimer’s Trust to Improve Alzheimer’s Disease Diagnosis Read More »

Cambridge Cognition
Scroll to Top